Searched for
AYURVEDIC PRODUCTS
Dabur’s Sesa Care merger gets NCLT approvalDabur India has obtained approval from the National Company Law Tribunal for merging with Sesa Care. This merger aims to strengthen Dabur's...- Stock Radar: Dabur India stock showing signs of bottoming out after falling by about 30% from highs; time to buy?Dabur India rebounded from Rs 350–360 levels and reclaimed its 20-DMA, while a Supertrend buy signal and positive EMA crossover supported i...
- Ayurveda eyes global growth as research, innovation reshape traditional systemAyurveda is gaining global relevance through research and innovation. Growing interest in holistic healthcare creates new international opp...
- Pickles, honey & curry pastes gain weight in India's export basketIndian kitchen staples are increasingly exported due to global demand for authentic flavors. Exports of pickles, honey, and pastes grew sig...
- Dabur challenges Delhi HC ruling in Emami trade dress rowUpholding the curbs on Dabur hair oil over Emami trade dress, the HC's division bench in May said that Dabur had been rightly restrained be...
- Merchant Navy professional quit his job to transform his gooseberry farm. His earnings boomed from Rs 45,000 to Rs 9 lakh per acreAfter realizing that raw amla sales were not lucrative, Shyam Singh's family pivoted to processing amla into juice and other by-products, r...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20% in one year, as per analystsWhen the stock market is hit by a mix of head and tail winds, it is probably the right time to look at stocks from sectors witnessing struc...
- D2C skincare brand Asaya raises Rs 88 crore funding at Rs 400 crore valuationDirect-to-consumer (D2C) skincare brand Asaya has raised Rs 88 crore at a post-money valuation of Rs 400 crore from RPSG Capital and other ...
- One of a Kind Awards: Celebrating the startups that earned the people’s voteAt the One of a Kind Awards - for early stage startups, presented by The Economic Times and Cashfree Payments, the People’s Choice Award re...
- Dabur, Ferns N Petals, Lotte India rectify labelling, advertising lapses after FSSAI noticesFood regulator FSSAI said Dabur India, Ferns N Petals, Lotte India and other food businesses have taken corrective measures after being fla...
- Dabur, Ferns N Petals and four other firms rectify labelling, ad violations after FSSAI noticesDabur India, Ferns N Petals and four other food businesses have taken corrective action after receiving notices from FSSAI over misleading ...
- Independence Day 2026: The Kolkata chemist who sold foreign medicines, backed Swadeshi and built a pharma empireIndependence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...
- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...
- Maharashtra FDA cracks down on Ayurvedic drug makers, cancels 10 licencesMaharashtra FDA has launched a statewide crackdown on Ayurvedic drug manufacturers. Inspections revealed serious violations of manufacturin...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Luxury hotel chains bet big on India's wellness boomIndian luxury hotel chains are investing heavily in wellness tourism. The Oberoi Group plans twenty new lifestyle resorts across India and ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
Load More
